Beyond the Myths: Protecting Autistic Lives, Public Health, and the Future of Science (Part 2)

Part 3: Why Autism Diagnoses Rose

If vaccines don’t cause autism, why do the numbers keep climbing? In the U.S., autism prevalence among 8-year-olds is now estimated at 1 in 31 (CDC, 2022) compared with 1 in 150 in 2000. Similar rises are seen in other high-income countries. To those who don’t follow the data closely, that curve looks like an epidemic. In reality, what’s grown is recognition, not incidence.

Broader diagnostic criteria

The definition of autism has changed significantly over the past three decades. The DSM-IV (1994) and DSM-5 (2013) consolidated what were once separate categories – autistic disorder, Asperger’s syndrome, PDD-NOS – into a single autism spectrum disorder (ASD). This shift meant more people, especially those with milder forms or atypical profiles, were brought under the umbrella.

Better case finding

Two generations ago, many autistic people – especially girls, non-white children, and those without intellectual disability – were misdiagnosed or missed entirely. Some were labelled “language impaired,” “emotionally disturbed,” or simply “difficult.” Today, screening tools are built into well-child visits. Educators are trained to notice early signs. Health systems are better at documenting and reporting cases.

Access and stigma

Historically, many families avoided the label. Institutionalisation loomed large, and stigma was punishing. Today, parents have more reason to seek a diagnosis – because it can unlock services, supports, and accommodations. That feedback loop naturally increases case counts.

Earlier identification

Autism traits often show by 18–24 months. Systematic screening at those ages means children are being identified earlier than ever before. That, too, increases prevalence numbers at younger ages.

Geographic patterns

Prevalence isn’t uniform. In U.S. surveillance, states with the best screening infrastructure report the highest autism prevalence. That tells us the numbers reflect system capacity as much as biology. In other words: the more you look, the more you find.

The real bottom line

Autism is not new. It has always been part of the human condition. What’s new is that we are counting more accurately and more inclusively. Rising prevalence tells us that fewer autistic people are being overlooked, hidden, or institutionalised.

That’s a story of progress – not an epidemic.

Next: Part 4 – What Does Increase Risk?

We’ll examine the strongest evidence for genuine autism risk factors: genetics, prenatal exposures like valproate, advanced parental age, and a handful of environmental suspects.

Part 4: What Does Increase Risk?

If vaccines don’t explain rising autism prevalence, what does science actually say about causes? The short answer is that autism is overwhelmingly neurodevelopmental and genetic, with some environmental influences during pregnancy and early life that can slightly shift risk. None are single “smoking guns.” Together they illustrate how complex – and how human – autism’s roots are.

Genetics: the strongest signal

Heritability is high. Twin studies and large family cohorts show autism is ~80% heritable. That doesn’t mean 80% of an individual’s risk is genetic, but that genetic variation explains most of the differences in who develops autism across the population.

Polygenic risk. For most autistic people, risk comes from hundreds of common genetic variants of small effect acting in combination.

Rare, large-effect mutations. In a minority of cases, autism is linked to specific de novo mutations (new variants not present in parents) or syndromes such as Fragile X, Rett, or tuberous sclerosis. These are individually rare but highly informative for biology.

Parental age. Advanced maternal and paternal age are associated with higher rates of autism in children. For fathers, this is partly due to the accumulation of new mutations in sperm with age.

Prenatal exposures with strong evidence

Valproate (antiseizure medication). Multiple large registry studies in Europe and North America show prenatal exposure increases autism risk in a dose-dependent way. Regulators now strongly warn against its use in pregnancy unless no alternatives exist.

Topiramate (another antiseizure drug). More recent data suggest a similar pattern, though with smaller effect sizes than valproate.

Congenital rubella. Before widespread rubella vaccination, congenital rubella infection was one of the clearest acquired causes of autism and intellectual disability. The fact that MMR protects against rubella underscores the irony of blaming vaccines for autism.

Environmental exposures under investigation

Air pollution (PM2.5, NO₂). Meta-analyses suggest small but consistent associations between prenatal/early life exposure and autism risk. Effects are modest and confounded by socioeconomic factors, but the signal appears across different countries.

Pesticides. Large California studies link maternal residential proximity to agricultural pesticide applications with increased autism odds, especially with organophosphates. These are observational data, but they’ve been replicated.

Endocrine disruptors (BPA, some phthalates). Evidence is mixed. Some cohort studies show associations, others don’t. Mechanistic animal data suggest plausibility, but human evidence is not yet conclusive.

Heavy metals (cadmium, lead, mercury). High exposures are neurotoxic, but evidence for autism specifically is inconsistent at today’s lower exposure levels.

What’s not supported

Vaccines. No association across dozens of large, high-quality studies.

Parental behaviour. The long-discredited “refrigerator mother” theory of autism, which blamed parenting style, was rooted in stigma, not science.

Putting it together

Autism arises from a genetic foundation, often present from conception, sometimes modified by early environmental influences. The strongest actionable risk factors today are medications and infections in pregnancy that can be avoided or managed safely. Others – air quality, pesticide exposure – are public-health issues where reductions benefit everyone, not just autism risk.

The reality is less dramatic than a single villain, but more powerful: small changes in policy, medical practice, and environment can shift outcomes for thousands of families. And none require scapegoating vaccines.

Next: Part 5 – Environmental Suspects, Ranked by Evidence.

We’ll zoom in on pollution, pesticides, plastics, and metals, sorting what’s most credible, what’s mixed, and what remains speculative.

Part 5: Environmental Suspects, Ranked by Evidence

If autism is primarily genetic, why do researchers keep probing environmental exposures? Because biology is rarely shaped by genes alone. Genes set the stage, but early environments – from the air we breathe to the chemicals we absorb – can nudge neurodevelopment in ways that matter. The challenge is separating weak signals from noise. Here’s where the evidence stands today.

1. Air pollution – most credible

Dozens of studies across North America, Europe, and Asia have tested the link between traffic-related air pollution and autism. A 2024 meta-analysis covering 29 studies found that higher prenatal exposure to fine particles (PM2.5) was consistently associated with modestly increased risk. Importantly, the association shows up even in lower-pollution countries such as Sweden, suggesting there may be no safe threshold.

What’s known: Prenatal and early-life exposure seems most important.

What’s plausible: Pollution particles may cross the placenta, trigger inflammation, or alter brain development.

Strength: Consistent, though modest. This is the clearest environmental signal so far.

2. Pesticides – solid but still observational

California’s detailed agricultural-use registries have allowed precise mapping of pesticide spraying around homes. Several large studies show increased odds of autism in children whose mothers lived near high levels of organophosphate or pyrethroid applications during pregnancy. One 2019 BMJ case-control study found up to a 50% increase when exposure continued into infancy.

What’s known: Associations are strongest for organophosphates such as chlorpyrifos (since banned in food use).

What’s plausible: These chemicals interfere with neurotransmission and brain development.

Strength: Stronger than chance, replicated in multiple cohorts, but still observational with confounders.

3. Plastics and endocrine disruptors – mixed

Bisphenol A (BPA) and some phthalates disrupt hormone systems that guide brain development. A 2024 Nature Communications study showed higher maternal BPA in late pregnancy was linked to more autism traits in boys with specific genetic variants – pointing to a gene–environment interaction. Other studies, however, show null results.

What’s known: BPA crosses the placenta and can alter hormone pathways.

What’s plausible: Effects may be subtle, depend on timing, or show up only in certain genetic backgrounds.

Strength: Emerging, not conclusive.

4. Heavy metals – inconsistent

High doses of lead and mercury are well-established neurotoxins, but evidence for autism specifically is uneven. A recent meta-analysis of high-risk pregnancies found early-pregnancy cadmium exposure linked to increased autism risk, while lead and mercury results were inconsistent.

What’s known: Heavy metals damage developing brains at high exposures.

What’s plausible: Today’s lower exposures may contribute in subtle ways, but evidence is thin.

Strength: Weak to moderate.

5. Microplastics and nanoplastics – too new to call

In 2025, researchers confirmed micro- and nanoplastics in human placentas, bloodstreams, and even brain tissue. That shows exposure reaches the most sensitive organs. But no study has yet linked microplastic exposure directly to autism risk.

What’s known: Exposure is real, widespread, and biologically plausible.

What’s plausible: Inflammation or disruption of fetal environments.

Strength: Speculative; urgent area for research.

What’s not on the list

Electromagnetic fields, Wi-Fi, food preservatives, and most consumer “toxins” often touted online show little to no evidence of affecting autism risk. They remain distractions from the more credible suspects above.

Bottom line

The strongest environmental leads are air pollution and pesticides, followed by suggestive but inconsistent signals for plastics and heavy metals. Microplastics are a research frontier. All of these are small influences compared to genetics, but they matter – because they are modifiable. Clean air, safer agriculture, and reduced chemical exposures improve health broadly, with autism risk as one part of the benefit.

Next: Part 6 – Mechanisms 101.

We’ll explore how genes and environment interact: immune activation, endocrine disruption, oxidative stress, and the developmental pathways that make timing everything.

Continued tomorrow…

Link to Part 1:

Beyond the Myths: Protecting Autistic Lives, Public Health, and the Future of Science (Part 1)

Link to Part 3:

Beyond the Myths: Protecting Autistic Lives, Public Health, and the Future of Science (Part 3)

Dear reader, we need your support

Independent sites such as The AIMN provide a platform for public interest journalists. From its humble beginning in January 2013, The AIMN has grown into one of the most trusted and popular independent media organisations.

One of the reasons we have succeeded has been due to the support we receive from our readers through their financial contributions.

With increasing costs to maintain The AIMN, we need this continued support.

Your donation – large or small – to help with the running costs of this site will be greatly appreciated.

You can donate through PayPal or credit card via the button below, or donate via bank transfer: BSB: 062500; A/c no: 10495969